FDA Inspection 1269771 — Hovione LLC

Hovione LLC — FEI 3006106736

The FDA completed an inspection of Hovione LLC on June 11, 2025 in East Windsor, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 11, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
East Windsor, NJ (United States)